Cargando…
Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy
Recent investigations reported that some subtypes from the Lund or The Cancer Genome Atlas (TCGA) classifications were most responsive to PD-L1 inhibitor treatment. However, the association between previously reported subtypes and immune checkpoint inhibitor (ICI) therapy responsiveness has been ins...
Autores principales: | Baek, Seung-Woo, Jang, In-Hwan, Kim, Seon-Kyu, Nam, Jong-Kil, Leem, Sun-Hee, Chu, In-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084828/ https://www.ncbi.nlm.nih.gov/pubmed/32182655 http://dx.doi.org/10.3390/ijms21051850 |
Ejemplares similares
-
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022) -
Identification of an immunotherapy-responsive molecular subtype of bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2019) -
Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022) -
Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma
por: Ning, Yang‐Min, et al.
Publicado: (2017) -
Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)